On Monday, Morgan Stanley (NYSE:MS)’s shares inclined 1.57% to $34.31.
MS has the market capitalization of $65.14 billion. The stock has P/B ratio of 0.96 while EPS was $1.61. Institutional ownership of the company was 58.70% while 1.94 billion shares were outstanding. Net profit margin of the Company was 8.30% while its gross profit margin was 86.90%. Share of the company moved above its SMA 50 with 3.96%. ROE ratio was 4.70% while ROI was 0.80%. The mean estimate for the short term price target for Morgan Stanley (NYSE:MS) stands at $38.20 according to 23 Analysts. The higher price target estimate for the stock has been calculated at $46.00 while the lower price target estimate is at $31.00. Morgan Stanley (NYSE:MS) is a financial holding company. Through its subsidiaries and affiliates, the Company provides a variety of products and financial services to a group of clients and customers, including corporations, governments, financial institutions and individuals.
Allscripts Healthcare Solutions Inc (NASDAQ:MDRX)’s shares dropped -0.39% to $15.23.
So far in 2015, the company has a year-to-date performance of 19.26%. The stock, as of last close, traded 34.42% up from its 52 week low and was -1.17% below its 52 week high. Its latest closing price was 13.16% above the SMA200 while the distance from SMA 50 and SMA 20 was 10.22% and 3.48% respectively. The mean estimate for the short term price target for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) stands at $16.17 according to 21 Analysts. The higher price target estimate for the stock has been calculated at $20.00 while the lower price target estimate is at $12.00. Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) is engaged in engaged in delivering Information Technology (IT) and services. The Company sells its solutions to physicians, hospitals, governments, health systems, health plans, retail clinics, retail pharmacies, pharmacy benefit managers and post-acute organizations, such as home health and hospice agencies.
At the end of Monday’s trade, Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)‘s shares surged 8.42% to $1.03.
SNSS has market capitalization of $71.70 billion. Its current ratio was 1.90 while its shares were above its 50 days simple moving average with 12.14%. The company offered earning per share of $-0.37 while its 75.47 million shares were outstanding. YTD performance of the company was -59.61%. Stock volatility for the week was 6.58% while for the month it was shown at 7.94%. The mean estimate for the short term price target for Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) stands at $2.19 according to 4 Analysts. The higher price target estimate for the stock has been calculated at $3.00 while the lower price target estimate is at $0.75. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The Company’s program is QINPREZOTM (vosaroxin), which is its product candidate for the treatment of acute myeloid leukemia (AML).
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.